{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:11:04Z","timestamp":1793409064087,"version":"4.5.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["19IPLOI34760325"],"award-info":[{"award-number":["19IPLOI34760325"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["3210496"],"award-info":[{"award-number":["3210496"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL147545"],"award-info":[{"award-number":["R01HL147545"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["947398"],"award-info":[{"award-number":["947398"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK126975"],"award-info":[{"award-number":["R01DK126975"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["7-20-IBS-218"],"award-info":[{"award-number":["7-20-IBS-218"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018735","name":"Fondo de Financiamiento de Centros de Investigaci\u00f3n en \u00c1reas Prioritarias","doi-asserted-by":"publisher","award":["1523A0008"],"award-info":[{"award-number":["1523A0008"]}],"id":[{"id":"10.13039\/501100018735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018735","name":"Fondo de Financiamiento de Centros de Investigaci\u00f3n en \u00c1reas Prioritarias","doi-asserted-by":"publisher","award":["1200490"],"award-info":[{"award-number":["1200490"]}],"id":[{"id":"10.13039\/501100018735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018735","name":"Fondo de Financiamiento de Centros de Investigaci\u00f3n en \u00c1reas Prioritarias","doi-asserted-by":"publisher","award":["1513001"],"award-info":[{"award-number":["1513001"]}],"id":[{"id":"10.13039\/501100018735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018735","name":"Fondo de Financiamiento de Centros de Investigaci\u00f3n en \u00c1reas Prioritarias","doi-asserted-by":"publisher","award":["1240443"],"award-info":[{"award-number":["1240443"]}],"id":[{"id":"10.13039\/501100018735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"Agencia Nacional de Promocion de la Investigacion el Desarrollo Tecnologico y la Innovacion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.bbadis.2024.167038","type":"journal-article","created":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T06:38:56Z","timestamp":1706337536000},"page":"167038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["NAD in pathological cardiac remodeling: Metabolic regulation and beyond"],"prefix":"10.1016","volume":"1870","author":[{"given":"Ignacio","family":"Norambuena-Soto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfeng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Lavandero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao V.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tibs.2006.11.006","article-title":"NAD+ metabolism in health and disease","volume":"32","author":"Belenky","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbadis.2024.167038_bb0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.nutr.28.061807.155443","article-title":"Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition","volume":"28","author":"Bogan","year":"2008","journal-title":"Annu. Rev. Nutr."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167038_bb0015","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0092-8674(04)00416-7","article-title":"Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans","volume":"117","author":"Bieganowski","year":"2004","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-020-00311-7","article-title":"NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"35","key":"10.1016\/j.bbadis.2024.167038_bb0025","doi-asserted-by":"crossref","first-page":"33049","DOI":"10.1074\/jbc.M302257200","article-title":"Eukaryotic NAD+ synthetase Qns1 contains an essential, obligate intramolecular thiol glutamine amidotransferase domain related to nitrilase","volume":"278","author":"Bieganowski","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bbadis.2024.167038_bb0030","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.cmet.2018.03.018","article-title":"Quantitative analysis of NAD synthesis-breakdown fluxes","volume":"27","author":"Liu","year":"2018","journal-title":"Cell Metab."},{"issue":"32","key":"10.1016\/j.bbadis.2024.167038_bb0035","doi-asserted-by":"crossref","first-page":"22439","DOI":"10.1074\/jbc.M513919200","article-title":"Synthetic lethal and biochemical analyses of NAD and NADH kinases in Saccharomyces cerevisiae establish separation of cellular functions","volume":"281","author":"Bieganowski","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1615\/CritRevEukaryotGeneExpr.2013006875","article-title":"Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases","volume":"24","author":"Morales","year":"2014","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167038_bb0045","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1021\/acs.chemrev.7b00122","article-title":"ADP-ribosylation, a multifaceted posttranslational modification involved in the control of cell physiology in health and disease","volume":"118","author":"L\u00fcscher","year":"2018","journal-title":"Chem. Rev."},{"issue":"52","key":"10.1016\/j.bbadis.2024.167038_bb0050","doi-asserted-by":"crossref","first-page":"17986","DOI":"10.1074\/jbc.RA120.015138","article-title":"Coronavirus infection and PARP expression dysregulate the NAD metabolome: an actionable component of innate immunity","volume":"295","author":"Heer","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167038_bb0055","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/lifemeta\/loac025","article-title":"Sirtuins are not conserved longevity genes","volume":"1","author":"Brenner","year":"2022","journal-title":"Life Metab."},{"key":"10.1016\/j.bbadis.2024.167038_bb0060","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.ddtec.2012.08.003","article-title":"The controversial world of sirtuins","volume":"12","author":"Dang","year":"2014","journal-title":"Drug Discov. Today Technol."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/cells9010052","article-title":"The good, the bad and the unknown of CD38 in the metabolic microenvironment and immune cell functionality of solid tumors","volume":"9","author":"Konen","year":"2019","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.bbadis.2024.167038_bb0070","doi-asserted-by":"crossref","first-page":"12565","DOI":"10.1096\/fj.202001249R","article-title":"Interleukin-8 drives CD38 to form NAADP from NADP+ and NAAD in the endolysosomes to mobilize Ca2+ and effect cell migration","volume":"34","author":"Nam","year":"2020","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167038_bb0075","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.neuron.2021.02.009","article-title":"SARM1 is a metabolic sensor activated by an increased NMN\/NAD+ ratio to trigger axon degeneration","volume":"109","author":"Figley","year":"2021","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.bbadis.2024.167038_bb0080","doi-asserted-by":"crossref","first-page":"H774","DOI":"10.1152\/ajpheart.00370.2022","article-title":"Sexually dimorphic effects of SARM1 deletion on cardiac NAD+ metabolism and function","volume":"323","author":"Nizami","year":"2022","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167038_bb0085","doi-asserted-by":"crossref","first-page":"103812","DOI":"10.1016\/j.isci.2022.103812","article-title":"SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites","volume":"25","author":"Angeletti","year":"2022","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.bbadis.2024.167038_bb0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","article-title":"NAD+ intermediates: the biology and therapeutic potential of NMN and NR","volume":"27","author":"Yoshino","year":"2018","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","article-title":"NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus","volume":"22","author":"Canto","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2024.167038_bb0100","doi-asserted-by":"crossref","first-page":"113829","DOI":"10.1016\/j.bcp.2020.113829","article-title":"Nicotinic acid transport into human liver involves organic anion transporter 2 (SLC22A7)","volume":"174","author":"Mathialagan","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2024.167038_bb0105","doi-asserted-by":"crossref","first-page":"13103","DOI":"10.1038\/ncomms13103","article-title":"NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells","volume":"7","author":"Ratajczak","year":"2016","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.bbadis.2024.167038_bb0110","doi-asserted-by":"crossref","first-page":"21767","DOI":"10.1074\/jbc.M110.213298","article-title":"Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation","volume":"286","author":"Nikiforov","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s42255-018-0009-4","article-title":"Slc12a8 is a nicotinamide mononucleotide transporter","volume":"1","author":"Grozio","year":"2019","journal-title":"Nat. Metab."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167038_bb0120","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s42255-019-0085-0","article-title":"Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter","volume":"1","author":"Schmidt","year":"2019","journal-title":"Nat. Metab."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167038_bb0125","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s42255-019-0086-z","article-title":"Reply to: Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter","volume":"1","author":"Grozio","year":"2019","journal-title":"Nat. Metab."},{"issue":"21","key":"10.1016\/j.bbadis.2024.167038_bb0130","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1161\/CIRCULATIONAHA.116.026099","article-title":"Nicotinamide riboside preserves cardiac function in a mouse model of dilated cardiomyopathy","volume":"137","author":"Diguet","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0135","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1038\/s41467-019-11732-6","article-title":"PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma","volume":"10","author":"Fons","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167038_bb0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD+ metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"42","key":"10.1016\/j.bbadis.2024.167038_bb0145","doi-asserted-by":"crossref","first-page":"10654","DOI":"10.1073\/pnas.1809392115","article-title":"Pharmacological bypass of NAD+ salvage pathway protects neurons from chemotherapy-induced degeneration","volume":"115","author":"Liu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.bbadis.2024.167038_bb0150","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1096\/fj.201700221RR","article-title":"Nicotinamide riboside, a form of vitamin B3, protects against excitotoxicity-induced axonal degeneration","volume":"31","author":"Vaur","year":"2017","journal-title":"FASEB J."},{"issue":"22","key":"10.1016\/j.bbadis.2024.167038_bb0155","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.121.056589","article-title":"NAD+ metabolism in cardiac health, aging, and disease","volume":"144","author":"Abdellatif","year":"2021","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.bbadis.2024.167038_bb0160","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/CIRCRESAHA.109.203703","article-title":"Nicotinamide phosphoribosyl- transferase regulates cell survival through NAD+ synthesis in cardiac myocytes","volume":"105","author":"Hsu","year":"2009","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167038_bb0165","doi-asserted-by":"crossref","first-page":"H711","DOI":"10.1152\/ajpheart.00222.2019","article-title":"Both gain and loss of Nampt function promote pressure overload-induced heart failure","volume":"317","author":"Byun","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2024.167038_bb0170","doi-asserted-by":"crossref","first-page":"15857","DOI":"10.1038\/srep15857","article-title":"Monocyte-derived extracellular Nampt-dependent biosynthesis of NAD+ protects the heart against pressure overload","volume":"5","author":"Yano","year":"2015","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167038_bb0175","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.3390\/ijms22073534","article-title":"NMRK2 gene is upregulated in dilated cardiomyopathy and required for cardiac function and NAD levels during aging","volume":"22","author":"Tannous","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167038_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165609","article-title":"Nicotinamide riboside kinase-2 alleviates ischemia-induced heart failure through P38 signaling","volume":"866","author":"Ahmad","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0185","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCRESAHA.120.317943","article-title":"Nampt potentiates antioxidant defense in diabetic cardiomyopathy","volume":"129","author":"Oka","year":"2021","journal-title":"Circ. Res."},{"issue":"580","key":"10.1016\/j.bbadis.2024.167038_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd7064","article-title":"Nicotinamide for the treatment of heart failure with preserved ejection fraction","volume":"13","author":"Abdellatif","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167038_bb0195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/jpet.122.001122","article-title":"Cardioprotective effects of 1-(3,6-dibromo-carbazol-9-yl)-3-phenylamino-propan-2-Ol in diabetic hearts via nicotinamide phosphoribosyltransferase activation","volume":"382","author":"Tur","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"22","key":"10.1016\/j.bbadis.2024.167038_bb0200","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1093\/hmg\/ddy278","article-title":"Rescue of biosynthesis of nicotinamide adenine dinucleotide protects the heart in cardiomyopathy caused by lamin A\/C gene mutation","volume":"27","author":"Vignier","year":"2018","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.bbadis.2024.167038_bb0205","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/CIRCRESAHA.120.317046","article-title":"NAD+ repletion reverses heart failure with preserved ejection fraction","volume":"128","author":"Tong","year":"2021","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.bbadis.2024.167038_bb0210","doi-asserted-by":"crossref","first-page":"22299","DOI":"10.3390\/ijms160922299","article-title":"Association of nicotinamide phosphoribosyltransferase (NAMPT) gene polymorphisms and of serum NAMPT levels with dilated cardiomyopathy in a Chinese population","volume":"16","author":"Dou","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2024.167038_bb0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.yjmcc.2018.10.001","article-title":"Augmentation of NAD+ levels by enzymatic action of NAD(P)H quinone oxidoreductase 1 attenuates adriamycin-induced cardiac dysfunction in mice","volume":"124","author":"Khadka","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5","key":"10.1016\/j.bbadis.2024.167038_bb0220","doi-asserted-by":"crossref","first-page":"H1466","DOI":"10.1152\/ajpheart.00795.2008","article-title":"Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro","volume":"296","author":"Mukhopadhyay","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbadis.2024.167038_bb0225","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59828","article-title":"Instability in NAD+ metabolism leads to impaired cardiac mitochondrial function and communication","volume":"10","author":"Lauritzen","year":"2021","journal-title":"eLife"},{"issue":"3","key":"10.1016\/j.bbadis.2024.167038_bb0230","first-page":"3722","article-title":"Liraglutide repairs the infarcted heart: the role of the SIRT1\/Parkin\/mitophagy pathway","volume":"17","author":"Qiao","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbadis.2024.167038_bb0235","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yjmcc.2018.02.015","article-title":"Genetic deletion of CD38 confers post-ischemic myocardial protection through preserved pyridine nucleotides","volume":"118","author":"Boslett","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167038_bb0240","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.bbadis.2024.167038_bb0245","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1161\/HYP.0000000000000090","article-title":"Animal models of hypertension: a scientific statement from the American Heart Association","volume":"73","author":"Lerman","year":"2019","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.bbadis.2024.167038_bb0250","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1074\/jbc.M109.077271","article-title":"Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway","volume":"285","author":"Pillai","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167038_bb0255","doi-asserted-by":"crossref","first-page":"H1197","DOI":"10.1152\/ajpheart.00483.2001","article-title":"Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats","volume":"282","author":"Cox","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"12","key":"10.1016\/j.bbadis.2024.167038_bb0260","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/CIRCULATIONAHA.116.022495","article-title":"Normalization of NAD+ redox balance as a therapy for heart failure","volume":"134","author":"Lee","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0265","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","article-title":"The sirtuin family in health and disease","volume":"7","author":"Wu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2024.167038_bb0270","doi-asserted-by":"crossref","first-page":"5546867","DOI":"10.1155\/2021\/5546867","article-title":"Nicotinamide riboside alleviates cardiac dysfunction and remodeling in pressure overload cardiac hypertrophy","volume":"2021","author":"Ma","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"12","key":"10.1016\/j.bbadis.2024.167038_bb0275","doi-asserted-by":"crossref","first-page":"914","DOI":"10.18632\/aging.100252","article-title":"Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy","volume":"2","author":"Hafner","year":"2010","journal-title":"Aging"},{"issue":"3","key":"10.1016\/j.bbadis.2024.167038_bb0280","article-title":"Mouse SIRT3 attenuates hypertrophy-related lipid accumulation in the heart through the deacetylation of LCAD","volume":"10","author":"Chen","year":"2015","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.bbadis.2024.167038_bb0285","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00395-015-0493-6","article-title":"SIRT3 deficiency impairs mitochondrial and contractile function in the heart","volume":"110","author":"Koentges","year":"2015","journal-title":"Basic Res. Cardiol."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167038_bb0290","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1536\/ihj.21-332","article-title":"Downregulation of lncRNA MALAT1 inhibits angiotensin II-induced hypertrophic effects of cardiomyocytes by regulating SIRT4 via miR-93-5p","volume":"63","author":"Ji","year":"2022","journal-title":"Int. Heart J."},{"issue":"18","key":"10.1016\/j.bbadis.2024.167038_bb0295","first-page":"1389","article-title":"SIRT4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity","volume":"38","author":"Luo","year":"2017","journal-title":"Eur. Heart J."},{"issue":"16","key":"10.1016\/j.bbadis.2024.167038_bb0300","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1073\/pnas.1519858113","article-title":"Metabolomics-assisted proteomics identifies succinylation and SIRT5 as important regulators of cardiac function","volume":"113","author":"Sadhukhan","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"48","key":"10.1016\/j.bbadis.2024.167038_bb0305","doi-asserted-by":"crossref","first-page":"19767","DOI":"10.1074\/jbc.M117.809897","article-title":"Sirtuin 5 is required for mouse survival in response to cardiac pressure overload","volume":"292","author":"Hershberger","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"27","key":"10.1016\/j.bbadis.2024.167038_bb0310","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1074\/jbc.RA118.002187","article-title":"Ablation of Sirtuin5 in the postnatal mouse heart results in protein succinylation and normal survival in response to chronic pressure overload","volume":"293","author":"Hershberger","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0315","doi-asserted-by":"crossref","first-page":"12258","DOI":"10.1038\/s41598-022-16506-7","article-title":"Sirtuin 5 levels are limiting in preserving cardiac function and suppressing fibrosis in response to pressure overload","volume":"12","author":"Guo","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167038_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211796","article-title":"SIRT5 deficiency suppresses mitochondrial ATP production and promotes AMPK activation in response to energy stress","volume":"14","author":"Zhang","year":"2019","journal-title":"PloS One"},{"issue":"21","key":"10.1016\/j.bbadis.2024.167038_bb0325","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.117.028728","article-title":"SIRT2 acts as a cardioprotective deacetylase in pathological cardiac hypertrophy","volume":"136","author":"Tang","year":"2017","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.bbadis.2024.167038_bb0330","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1074\/jbc.RA117.000915","article-title":"SIRT2 deacetylase represses NFAT transcription factor to maintain cardiac homeostasis","volume":"293","author":"Sarikhani","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2024.167038_bb0335","doi-asserted-by":"crossref","first-page":"119299","DOI":"10.1016\/j.lfs.2021.119299","article-title":"Nicotinamide mononucleotide attenuates isoproterenol-induced cardiac fibrosis by regulating oxidative stress and Smad3 acetylation","volume":"274","author":"Wu","year":"2021","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.bbadis.2024.167038_bb0340","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/nm.2961","article-title":"The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun","volume":"18","author":"Sundaresan","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2024.167038_bb0345","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fphys.2017.00394","article-title":"Cardioprotective effects of SIRT6 in a mouse model of transverse aortic constriction-induced heart failure","volume":"8","author":"Li","year":"2017","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0350","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1476-5381.2012.01903.x","article-title":"Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-kappaB-dependent transcriptional activity","volume":"168","author":"Yu","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167038_bb0355","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/CIRCRESAHA.107.164558","article-title":"Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice","volume":"102","author":"Vakhrusheva","year":"2008","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0360","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/HYPERTENSIONAHA.119.13357","article-title":"Cardiomyocyte sirt (sirtuin) 7 ameliorates stress-induced cardiac hypertrophy by interacting with and deacetylating GATA4","volume":"75","author":"Yamamura","year":"2020","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"issue":"6","key":"10.1016\/j.bbadis.2024.167038_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098972","article-title":"Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion","volume":"9","author":"Yamamoto","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.bbadis.2024.167038_bb0370","doi-asserted-by":"crossref","first-page":"7410257","DOI":"10.1155\/2016\/7410257","article-title":"CD38 deficiency protects the heart from ischemia\/reperfusion injury through activating SIRT1\/FOXOs-mediated antioxidative stress pathway","volume":"2016","author":"Guan","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"17","key":"10.1016\/j.bbadis.2024.167038_bb0375","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1161\/CIRCULATIONAHA.119.041664","article-title":"Kruppel-like factor 15 regulates the circadian susceptibility to ischemia reperfusion injury in the heart","volume":"141","author":"Li","year":"2020","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.bbadis.2024.167038_bb0380","first-page":"6066","article-title":"Exogenous supplemental NAD+ protect myocardium against myocardial ischemic\/reperfusion injury in swine model","volume":"11","author":"Zhai","year":"2019","journal-title":"Am. J. Transl. Res."},{"issue":"8","key":"10.1016\/j.bbadis.2024.167038_bb0385","first-page":"3342","article-title":"Exogenous NAD+ administration significantly protects against myocardial ischemia\/reperfusion injury in rat model","volume":"8","author":"Zhang","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bbadis.2024.167038_bb0390","doi-asserted-by":"crossref","first-page":"172520","DOI":"10.1016\/j.ejphar.2019.172520","article-title":"Exogenous nicotinamide adenine dinucleotide administration alleviates ischemia\/reperfusion-induced oxidative injury in isolated rat hearts via Sirt5-SDH-succinate pathway","volume":"858","author":"Liu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"21","key":"10.1016\/j.bbadis.2024.167038_bb0395","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.110.958033","article-title":"Silent information regulator 1 protects the heart from ischemia\/reperfusion","volume":"122","author":"Hsu","year":"2010","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.bbadis.2024.167038_bb0400","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/1074248419882002","article-title":"Melatonin and nicotinamide mononucleotide attenuate myocardial ischemia\/reperfusion injury via modulation of mitochondrial function and hemodynamic parameters in aged rats","volume":"25","author":"Hosseini","year":"2020","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167038_bb0405","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1007\/s11033-021-06351-8","article-title":"Nicotinamide mononucleotide and melatonin counteract myocardial ischemia-reperfusion injury by activating SIRT3\/FOXO1 and reducing apoptosis in aged male rats","volume":"48","author":"Jafari-Azad","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167038_bb0410","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.phrs.2010.01.008","article-title":"Nicotinamide-rich diet protects the heart against ischaemia-reperfusion in mice: a crucial role for cardiac SUR2A","volume":"61","author":"Sukhodub","year":"2010","journal-title":"Pharmacol. Res."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2024.167038_bb0415","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000338628","article-title":"Nicotinamide pretreatment protects cardiomyocytes against hypoxia-induced cell death by improving mitochondrial stress","volume":"90","author":"Tong","year":"2012","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0420","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/10717544.2021.1886198","article-title":"Oral delivery of carrier-free dual-drug nanocrystal self-assembled microspheres improved NAD+ bioavailability and attenuated cardiac ischemia\/reperfusion injury in mice","volume":"28","author":"Nie","year":"2021","journal-title":"Drug Deliv."},{"issue":"12","key":"10.1016\/j.bbadis.2024.167038_bb0425","doi-asserted-by":"crossref","first-page":"H1602","DOI":"10.1152\/ajpheart.00027.2014","article-title":"SIRT3 deficiency exacerbates ischemia-reperfusion injury: implication for aged hearts","volume":"306","author":"Porter","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167038_bb0430","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s12265-021-10184-y","article-title":"SIRT6 protects against myocardial ischemia-reperfusion injury by attenuating aging-related CHMP2B accumulation","volume":"15","author":"Li","year":"2022","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0435","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1124\/jpet.118.254557","article-title":"Inhibition of CD38 with the thiazoloquin (az)olin(on)e 78c protects the heart against postischemic injury","volume":"369","author":"Boslett","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"10.1016\/j.bbadis.2024.167038_bb0440","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1161\/CIRCRESAHA.122.320334","article-title":"Animal models of dysregulated cardiac metabolism","volume":"130","author":"Bugger","year":"2022","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.bbadis.2024.167038_bb0445","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.tem.2014.06.006","article-title":"Insights into obesity and diabetes at the intersection of mouse and human genetics","volume":"25","author":"Kebede","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bbadis.2024.167038_bb0450","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2022.03.012","article-title":"Nicotinamide riboside promotes Mfn2-mediated mitochondrial fusion in diabetic hearts through the SIRT1-PGC1alpha-PPARalpha pathway","volume":"183","author":"Hu","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"8","key":"10.1016\/j.bbadis.2024.167038_bb0455","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008170","article-title":"NAD+ redox imbalance in the heart exacerbates diabetic cardiomyopathy","volume":"14","author":"Chiao","year":"2021","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.bbadis.2024.167038_bb0460","doi-asserted-by":"crossref","first-page":"118596","DOI":"10.1016\/j.lfs.2020.118596","article-title":"Nicotinamide riboside reduces cardiometabolic risk factors and modulates cardiac oxidative stress in obese Wistar rats under caloric restriction","volume":"263","author":"de Castro","year":"2020","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167038_bb0465","first-page":"388","article-title":"Sirt1 and Sirt3 activation improved cardiac function of diabetic rats via modulation of mitochondrial function","volume":"10","author":"Paramesha","year":"2021","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2024.167038_bb0470","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yexcr.2018.10.003","article-title":"PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1alpha axis","volume":"373","author":"Waldman","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"10","key":"10.1016\/j.bbadis.2024.167038_bb0475","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1096\/fj.201900767R","article-title":"The nuclear and mitochondrial sirtuins, Sirt6 and Sirt3, regulate each other\u2019s activity and protect the heart from developing obesity-mediated diabetic cardiomyopathy","volume":"33","author":"Kanwal","year":"2019","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.bbadis.2024.167038_bb0480","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018913","article-title":"Sirtuin 3 alleviates diabetic cardiomyopathy by regulating TIGAR and cardiomyocyte metabolism","volume":"10","author":"Li","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167038_bb0485","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41401-020-0490-7","article-title":"Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation","volume":"42","author":"Song","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.bbadis.2024.167038_bb0490","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3892\/mmr.2021.12006","article-title":"SIRT6-specific inhibitor OSS-128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress","volume":"23","author":"Huang","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"10.1016\/j.bbadis.2024.167038_bb0495","first-page":"161","article-title":"Cardiotoxicity and oncological treatments","volume":"111","author":"Schlitt","year":"2014","journal-title":"Deutsch. Arztebl. Int."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167038_bb0500","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11864-020-0719-1","article-title":"Cardiotoxicities of 5-fluorouracil and other fluoropyrimidines","volume":"21","author":"Shiga","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167038_bb0505","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1517\/14740330902733961","article-title":"Fluoropyrimidine-associated cardiotoxicity: revisited","volume":"8","author":"Saif","year":"2009","journal-title":"Expert Opin. Drug Saf."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167038_bb0510","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000471759","article-title":"A prospective study to evaluate the effect of paclitaxel on cardiac ejection fraction","volume":"12","author":"Osman","year":"2017","journal-title":"Breast Care (Basel, Switzerland)"},{"issue":"9","key":"10.1016\/j.bbadis.2024.167038_bb0515","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1200\/JCO.1991.9.9.1704","article-title":"Cardiac disturbances during the administration of taxol","volume":"9","author":"Rowinsky","year":"1991","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2024.167038_bb0520","doi-asserted-by":"crossref","first-page":"847012","DOI":"10.3389\/fcvm.2022.847012","article-title":"Cardiotoxicity of anticancer drugs: molecular mechanisms and strategies for cardioprotection","volume":"9","author":"Morelli","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.bbadis.2024.167038_bb0525","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.bbadis.2024.167038_bb0530","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":"Risk factors for doxorubicin-induced congestive heart failure","volume":"91","author":"Von Hoff","year":"1979","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbadis.2024.167038_bb0535","doi-asserted-by":"crossref","first-page":"736854","DOI":"10.3389\/fcvm.2021.736854","article-title":"Risk factors for anthracycline-induced cardiotoxicity","volume":"8","author":"Qiu","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bbadis.2024.167038_bb0540","doi-asserted-by":"crossref","first-page":"111679","DOI":"10.1016\/j.biopha.2021.111679","article-title":"Comparative study on beneficial effects of vitamins B and D in attenuating doxorubicin induced cardiotoxicity in rats: emphasis on calcium homeostasis","volume":"140","author":"Awad","year":"2021","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"issue":"39","key":"10.1016\/j.bbadis.2024.167038_bb0545","doi-asserted-by":"crossref","first-page":"19626","DOI":"10.1073\/pnas.1904979116","article-title":"p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities","volume":"116","author":"Li","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.bbadis.2024.167038_bb0550","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1042\/CS20181022","article-title":"Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity","volume":"133","author":"Zheng","year":"2019","journal-title":"Clin. Sci. (London, England: 1979)"},{"issue":"17","key":"10.1016\/j.bbadis.2024.167038_bb0555","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1093\/cvr\/cvac026","article-title":"SIRT1 in the cardiomyocyte counteracts doxorubicin-induced cardiotoxicity via regulating histone H2AX","volume":"118","author":"Kuno","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167038_bb0560","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1159\/000373937","article-title":"SIRT1 suppresses doxorubicin-induced cardiotoxicity by regulating the oxidative stress and p38MAPK pathways","volume":"35","author":"Ruan","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0565","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10565-021-09649-2","article-title":"Sirt6 protects cardiomyocytes against doxorubicin-induced cardiotoxicity by inhibiting P53\/Fas-dependent cell death and augmenting endogenous antioxidant defense mechanisms","volume":"39","author":"Wu","year":"2021","journal-title":"Cell Biol. Toxicol."},{"issue":"17","key":"10.1016\/j.bbadis.2024.167038_bb0570","doi-asserted-by":"crossref","first-page":"10981","DOI":"10.1074\/jbc.M114.607960","article-title":"Sirtuin-3 (SIRT3) protein attenuates doxorubicin-induced oxidative stress and improves mitochondrial respiration in H9c2 cardiomyocytes","volume":"290","author":"Cheung","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bbadis.2024.167038_bb0575","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008547","article-title":"Mitochondrial sirtuin-3 (SIRT3) prevents doxorubicin-induced dilated cardiomyopathy by modulating protein acetylation and oxidative stress","volume":"15","author":"Tomczyk","year":"2022","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.bbadis.2024.167038_bb0580","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yjmcc.2017.09.001","article-title":"Short-term administration of nicotinamide mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure","volume":"112","author":"Zhang","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"14","key":"10.1016\/j.bbadis.2024.167038_bb0585","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93885","article-title":"Nicotinamide mononucleotide requires SIRT3 to improve cardiac function and bioenergetics in a Friedreich\u2019s ataxia cardiomyopathy model","volume":"2","author":"Martin","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbadis.2024.167038_bb0590","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.yjmcc.2021.12.015","article-title":"Mitochondrial protein hyperacetylation underpins heart failure with preserved ejection fraction in mice","volume":"165","author":"Liu","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.bbadis.2024.167038_bb0595","doi-asserted-by":"crossref","first-page":"465","DOI":"10.33594\/000000151","article-title":"Mitochondrial hyperacetylation in the failing hearts of obese patients mediated partly by a reduction in SIRT3: the involvement of the mitochondrial permeability transition pore","volume":"53","author":"Castillo","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"issue":"6","key":"10.1016\/j.bbadis.2024.167038_bb0600","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/10409238.2013.838204","article-title":"Mitochondrial protein acetylation as a cell-intrinsic, evolutionary driver of fat storage: chemical and metabolic logic of acetyl-lysine modifications","volume":"48","author":"Ghanta","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"11","key":"10.1016\/j.bbadis.2024.167038_bb0605","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCRESAHA.121.318988","article-title":"SIRT6 mitigates heart failure with preserved ejection fraction in diabetes","volume":"131","author":"Wu","year":"2022","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.bbadis.2024.167038_bb0610","doi-asserted-by":"crossref","first-page":"109190","DOI":"10.1016\/j.celrep.2021.109190","article-title":"SIRT6 transcriptionally regulates fatty acid transport by suppressing PPARgamma","volume":"35","author":"Khan","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2024.167038_bb0615","doi-asserted-by":"crossref","first-page":"5876841","DOI":"10.1155\/2021\/5876841","article-title":"SIRT5-related desuccinylation modification contributes to quercetin-induced protection against heart failure and high-glucose-prompted cardiomyocytes injured through regulation of mitochondrial quality surveillance","volume":"2021","author":"Chang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0620","doi-asserted-by":"crossref","first-page":"2174649","DOI":"10.1080\/13510002.2023.2174649","article-title":"Cystathionine gamma-lyase S-sulfhydrates SIRT1 to attenuate myocardial death in isoprenaline-induced heart failure","volume":"28","author":"Wu","year":"2023","journal-title":"Redox Rep."},{"key":"10.1016\/j.bbadis.2024.167038_bb0625","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbrc.2022.11.014","article-title":"Sirtuin 1 aggravates hypertrophic heart failure caused by pressure overload via shifting energy metabolism","volume":"637","author":"Van Le","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"14","key":"10.1016\/j.bbadis.2024.167038_bb0630","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/archinte.162.14.1568","article-title":"Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial","volume":"162","author":"Grundy","year":"2002","journal-title":"Arch. Intern. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2024.167038_bb0635","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/exd.13819","article-title":"Nicotinamide for photoprotection and skin cancer chemoprevention: a review of efficacy and safety","volume":"28","author":"Snaidr","year":"2019","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bbadis.2024.167038_bb0640","doi-asserted-by":"crossref","first-page":"12948","DOI":"10.1038\/ncomms12948","article-title":"Nicotinamide riboside is uniquely and orally bioavailable in mice and humans","volume":"7","author":"Trammell","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0645","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.1038\/s41598-019-46120-z","article-title":"Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults","volume":"9","author":"Conze","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bbadis.2024.167038_bb0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186459","article-title":"An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers","volume":"12","author":"Airhart","year":"2017","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.bbadis.2024.167038_bb0655","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1172\/JCI138538","article-title":"Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure","volume":"130","author":"Zhou","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.bbadis.2024.167038_bb0660","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jacbts.2022.06.012","article-title":"Safety and tolerability of nicotinamide riboside in heart failure with reduced ejection fraction","volume":"7","author":"Wang","year":"2022","journal-title":"JACC Basic Transl. Sci."},{"issue":"4","key":"10.1016\/j.bbadis.2024.167038_bb0665","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1113\/JP278752","article-title":"Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men","volume":"598","author":"Dollerup","year":"2020","journal-title":"J. Physiol."},{"issue":"7","key":"10.1016\/j.bbadis.2024.167038_bb0670","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.celrep.2019.07.043","article-title":"Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures","volume":"28","author":"Elhassan","year":"2019","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbadis.2024.167038_bb0675","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41467-018-03421-7","article-title":"Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults","volume":"9","author":"Martens","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbadis.2024.167038_bb0680","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/ajcn\/nqaa072","article-title":"Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans","volume":"112","author":"Remie","year":"2020","journal-title":"Am. J. Clin. Nutr."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924000231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924000231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T16:56:18Z","timestamp":1751216178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443924000231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":136,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0925443924000231"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167038","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NAD in pathological cardiac remodeling: Metabolic regulation and beyond","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167038"}}